Literature DB >> 2145595

In vivo tumor oxygen tension measurements for the evaluation of the efficiency of photodynamic therapy.

B J Tromberg1, A Orenstein, S Kimel, S J Barker, J Hyatt, J S Nelson, M W Berns.   

Abstract

Among the sequence of events which occur during photodynamic therapy (PDT) are depletion of oxygen and disruption of tumor blood flow. In order to more clearly understand these phenomena we have utilized transcutaneous oxygen electrodes to monitor tissue oxygen disappearance. These results provide, for the first time, non-invasive real-time information regarding the influence of light dose on tissue oxygenation during irradiation. Measurements were conducted on transplanted VX-2 skin carcinomas grown in the ears of New Zealand white rabbits. Rabbits were treated with Photofrin II and tumors were irradiated with up to 200 kJ/m2 (500 W/m2) of 630-nm light. Substantial reductions in tumor oxygen tension were observed upon administration of as little as 20 kJ/m2. For a series of brief irradiations, oxygen tension was modulated by the appearance of laser light. Tissue oxygen reversibility appeared to be dependent upon PDT dose. Long-term, irreversible tissue hypoxia was recorded in tumors for large (200 kJ/m2) fluences. These results suggest that transcutaneous oxygen tension may be useful as a general indicator of the effectiveness of PDT and as an in situ predictor of the energy required to elicit tumor damage.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2145595     DOI: 10.1111/j.1751-1097.1990.tb04193.x

Source DB:  PubMed          Journal:  Photochem Photobiol        ISSN: 0031-8655            Impact factor:   3.421


  23 in total

Review 1.  Imaging and photodynamic therapy: mechanisms, monitoring, and optimization.

Authors:  Jonathan P Celli; Bryan Q Spring; Imran Rizvi; Conor L Evans; Kimberley S Samkoe; Sarika Verma; Brian W Pogue; Tayyaba Hasan
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

2.  Intraoperative optical assessment of photodynamic therapy response of superficial oral squamous cell carcinoma.

Authors:  Daniel J Rohrbach; Nestor Rigual; Hassan Arshad; Erin C Tracy; Michelle T Cooper; Gal Shafirstein; Gregory Wilding; Mihai Merzianu; Heinz Baumann; Barbara W Henderson; Ulas Sunar
Journal:  J Biomed Opt       Date:  2016-01       Impact factor: 3.170

3.  Application of lower fluence rate for less microvasculature damage and greater cell-killing during photodynamic therapy.

Authors:  Tao Xu; Yingxing Li; Xing Wu
Journal:  Lasers Med Sci       Date:  2004-10-26       Impact factor: 3.161

4.  Application of lower fluence rate for less microvasculature damage and greater cell-killing during photodynamic therapy.

Authors:  Tao Xu; Yingxing Li; Xing Wu
Journal:  Lasers Med Sci       Date:  2005       Impact factor: 3.161

5.  Light delivery over extended time periods enhances the effectiveness of photodynamic therapy.

Authors:  Mukund Seshadri; David A Bellnier; Lurine A Vaughan; Joseph A Spernyak; Richard Mazurchuk; Thomas H Foster; Barbara W Henderson
Journal:  Clin Cancer Res       Date:  2008-05-01       Impact factor: 12.531

6. 

Authors:  C S Betz; A Leunig
Journal:  HNO       Date:  2004-02       Impact factor: 1.284

7.  An IR Navigation System for Pleural PDT.

Authors:  Timothy C Zhu; Xing Liang; Michele M Kim; Jarod C Finlay; Andreea Dimofte; Carmen Rodriguez; Charles B Simone; Joseph S Friedberg; Keith A Cengel
Journal:  Front Phys       Date:  2015-03

8.  Mechanisms in photodynamic therapy: part two-cellular signaling, cell metabolism and modes of cell death.

Authors:  Ana P Castano; Tatiana N Demidova; Michael R Hamblin
Journal:  Photodiagnosis Photodyn Ther       Date:  2005-03       Impact factor: 3.631

Review 9.  Photodynamic therapy: one step ahead with self-assembled nanoparticles.

Authors:  Pinar Avci; S Sibel Erdem; Michael R Hamblin
Journal:  J Biomed Nanotechnol       Date:  2014-09       Impact factor: 4.099

10.  Prostate PDT dosimetry.

Authors:  Timothy C Zhu; Jarod C Finlay
Journal:  Photodiagnosis Photodyn Ther       Date:  2006-10-19       Impact factor: 3.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.